All entries for: Entrada Therapeutics, Inc.

August 5, 2026

Entrada Therapeutics, Inc.

Neutral Outlook

Boston, MA
51-200 employees

The effect of the IRA on our business and the healthcare industry in general is not yet known.

Disease Area: Multiple, Neurological Diseases, Rare Diseases
Drug Type: Small Molecule
Scroll to Top